Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Quest Diagnostics | 14,107 | 2023q3 | |||||||||
QuidelOrtho | 3,129 | 2023 | |||||||||
Quince Therapeutics | 24 | 2021 | |||||||||
Recursion Pharmaceuticals | 1,614 | 2023 | |||||||||
Regeneron Pharmaceuticals | 105,002 | 2023q2 | |||||||||
REGENXBIO | 534 | 2023q3 | |||||||||
Relay Therapeutics | 838 | 2023q3 | |||||||||
RemeGen Co. | 1,191 | 2023 | |||||||||
Repare Therapeutics | 133 | 2022 | |||||||||
Repligen | 8,764 | 2023 | |||||||||
ResMed | 27,410 | 2024q2 | |||||||||
Revolution Medicines | 4,827 | 2023q3 | |||||||||
Revvity | 10,537 | 2023q3 | |||||||||
Rhythm Pharmaceuticals | 1,913 | 2021 | |||||||||
Rigel Pharmaceuticals | 185 | 2021 | |||||||||
Roche Holding | 194,784 | 2024q2 | |||||||||
Rocket Pharmaceuticals | 1,846 | 2023q3 | |||||||||
Sage Therapeutics | 799 | 2023q3 | |||||||||
Sana Biotechnology | 658 | 2023q3 | |||||||||
Sangamo Therapeutics | 91 | 2023q3 |